Anti-JAK2 (phospho Y1007 + Y1008)抗体[E132] (ab32101)

发表研究结果有使用 ab32101?请让我们知道,以便我们可以引用本数据表中的参考文章。

ab32101 被引用在 18 文献中.

  • Luo LN  et al. Osthole decreases renal ischemia-reperfusion injury by suppressing JAK2/STAT3 signaling activation. Exp Ther Med 12:2009-2014 (2016). WB ; Rat . PubMed: 27698686
  • Zhang Y  et al. Inhibition of casein kinase II reduces TGFß induced fibroblast activation and ameliorates experimental fibrosis. Ann Rheum Dis N/A:N/A (2014). PubMed: 24431397
  • Sedek M  et al. Multimeric growth hormone receptor complexes serve as signaling platforms. J Biol Chem 289:65-73 (2014). PubMed: 24280222
  • Liu W  et al. Epigallocatechin-3-gallate ameliorates seawater aspiration-induced acute lung injury via regulating inflammatory cytokines and inhibiting JAK/STAT1 pathway in rats. Mediators Inflamm 2014:612593 (2014). WB ; Rat . PubMed: 24692852
  • Gallipoli P  et al. JAK2/STAT5 inhibition by nilotinib with ruxolitinib contributes to the elimination of CML CD34+ cells in vitro and in vivo. Blood 124:1492-501 (2014). WB, Flow Cyt ; Mouse . PubMed: 24957147
  • Wu Q  et al. Crosstalk of JNK1-STAT3 is critical for RAW264.7 cell survival. Cell Signal 26:2951-60 (2014). Mouse . PubMed: 25269780
  • Yang JM  et al. Angiotensin-(1-7) dose-dependently inhibits atherosclerotic lesion formation and enhances plaque stability by targeting vascular cells. Arterioscler Thromb Vasc Biol 33:1978-85 (2013). WB ; Mouse . PubMed: 23723368
  • Fiskus W  et al. Dual PI3K/AKT/mTOR inhibitor BEZ235 synergistically enhances the activity of JAK2 inhibitor against cultured and primary human myeloproliferative neoplasm cells. Mol Cancer Ther 12:577-88 (2013). PubMed: 23445613
  • Chen CC  et al. Gene expression profiling for analysis acquired oxaliplatin resistant factors in human gastric carcinoma TSGH-S3 cells: the role of IL-6 signaling and Nrf2/AKR1C axis identification. Biochem Pharmacol 86:872-87 (2013). Human . PubMed: 23933386
  • Neviani P  et al. PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells. J Clin Invest 123:4144-57 (2013). PubMed: 23999433
  • Bao W  et al. A TrkB-STAT3-miR-204-5p regulatory circuitry controls proliferation and invasion of endometrial carcinoma cells. Mol Cancer 12:155 (2013). WB ; Human . PubMed: 24321270
  • Byrne R  et al. A dynamic real time in vivo and static ex vivo analysis of granulomonocytic cell migration in the collagen-induced arthritis model. PLoS One 7:e35194 (2012). IHC-P ; Mouse . PubMed: 22529989
  • Kirabo A  et al. Vascular smooth muscle Jak2 deletion prevents angiotensin II-mediated neointima formation following injury in mice. J Mol Cell Cardiol 50:1026-34 (2011). IHC-Fr ; Mouse . PubMed: 21420414
  • Fiskus W  et al. Heat Shock Protein 90 Inhibitor Is Synergistic with JAK2 Inhibitor and Overcomes Resistance to JAK2-TKI in Human Myeloproliferative Neoplasm Cells. Clin Cancer Res 17:7347-58 (2011). WB ; Human . PubMed: 21976548
  • Kirabo A  et al. The Jak2 Inhibitor, G6, Alleviates Jak2-V617F-Mediated Myeloproliferative Neoplasia by Providing Significant Therapeutic Efficacy to the Bone Marrow. Neoplasia 13:1058-68 (2011). IHC-P ; Mouse . PubMed: 22131881
  • Lin MH  et al. Epidermal hyperproliferation in mice lacking fatty acid transport protein 4 (FATP4) involves ectopic EGF receptor and STAT3 signaling. Dev Biol 344:707-19 (2010). IHC-P ; Mouse . PubMed: 20513444
  • Dawson MA  et al. JAK2 phosphorylates histone H3Y41 and excludes HP1alpha from chromatin. Nature 461:819-22 (2009). WB ; Human . PubMed: 19783980
  • Devi YS  et al. Regulation of transcription factors and repression of Sp1 by prolactin signaling through the short isoform of its cognate receptor. Endocrinology 150:3327-35 (2009). WB ; Rat . PubMed: 19342455